Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Chad Therapeutics has closed the sale of the assets related to company's oxygen conserving business to Inovo for $5.25 million in cash.
Subscribe to our email newsletter
Earl Yager, Chad’s president and CEO, said, “With additional proprietary products in an advanced stage of development and a roadmap of additional product development opportunities based on our patented technology, we believe we have the opportunity to build Chad’s position in this large and growing industry. In addition, we will continue to actively pursue the sale of our trans-filling assets.”